Korean J Urol.
2000 Sep;41(9):1063-1070.
Improved Quality of Life (QOL) During the Off-treatment Intervals of the Intermittent Androgen Deprivation (IAD) in the Prostate Cancer Patients
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Intermittent Androgen Deprivation with Goserelin and Flutamide for Prostate Cancer: a Pilot Study
- Differentiation Related Gene (Drg-1) as a Molecular Marker during the Treatment of in vitro Intermittent Androgen Deprivation in prostate Cancer
- Factors Predicting the Prolonged Duration of Off-treatment in Intermittent Androgen Deprivation of Prostate Cancer Treatment
- Intermittent Androgen Deprivation(IAD) with Cyproterone Acetate Monotherapy for Prostate Cancer: A preliminary report
- Quality of Life in Prostate Cancer Patient Undergoing Androgen Deprivation Therapy
